(Health-NewsWire.Net, July 29, 2016 ) The report "Active Pharmaceutical Ingredients Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020"
Browse 121 market data tables and 56 figures spread through 206 pages and in-depth TOC on “Active Pharmaceutical Ingredients Market"
http://www.marketsandmarkets.com/Market-Reports/API-Market-263.html
Early buyers will receive 10% customization on reports.
The report segments the APIs market based on types, type of manufacturer, type of synthesis, therapeutic area and regions. On the basis of type, the market is segmented into innovative and generic APIs. The innovative APIs segment is expected to account for the largest share of APIs market, by type, in 2015.
Among the type of manufacturer, the merchant APIs segment is expected to grow at the highest CAGR during the forecast period. Complexity and high expenses associated with in-house manufacturing of APIs as well as the increased competition from emerging contract manufacturers are propelling the growth of this segment.
Download PDF Brochure @
http://www.marketsandmarkets.com/pdfdownload.asp?id=263
Increasing global incidence of lifestyle and age-related diseases as well as cancer, technological advances in APIs manufacturing, increased awareness among people for better personal healthcare, government initiatives to increase availability and accessibility for better healthcare, and development of biologics and high potency APIs are propelling the growth of APIs market. On the other hand, the, stringent regulatory requirements and global economic recession may restrict market growth.
On the basis of region, the APIs market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015 and will continue to dominate the market during the forecast period. The Asian market is poised to grow at the highest CAGR, mainly due to low labor and manufacturing costs, increasing disposable income, increasing population with lifestyle and age related diseases and governmental emphasis on healthcare reforms.
Get Report Sample @
http://www.marketsandmarkets.com/requestsample.asp?id=263
The APIs market is highly fragmented and competitive, with several big as well as emerging market players. Key market players include Teva Pharmaceuticals limited (Israel), Sun Pharmaceuticals Industries Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Aurobindo (India), Novartis International AG (Switzerland), Boehringer Ingelheim (Germany), Albemarle Corporation (U.S.), Sigma-Aldrich (U.S.), Mylan (U.K.), Allergan plc.(Ireland),
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
|